Cargando…
Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes
We report a case of acute-onset type 1 diabetes due to combined application of nivolumab and intravesical Bacillus Calmette-Guérin (BCG). An 84-year-old woman underwent lung resection for pulmonary squamous cell carcinoma. She had been treated for type 2 diabetes and later experienced lung cancer re...
Autores principales: | Fujiu, Koichi, Fukaya, Yasuo, Kamimoto, Masahiro, Miyamoto, Hideaki, Cong, Yue, Suzuki, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600031/ https://www.ncbi.nlm.nih.gov/pubmed/31275133 http://dx.doi.org/10.1159/000500978 |
Ejemplares similares
-
Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015) -
Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy
por: Minakata, Tomokazu, et al.
Publicado: (2020) -
Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
por: Taniguchi, Yoshinori, et al.
Publicado: (2022) -
New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review
por: Takizawa, Tsubasa, et al.
Publicado: (2017) -
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)